Back to results
US 2025/0115680 A1Published application
Ptk7 binding agents, conjugates thereof and methods of using the same
AssigneeProfoundBio US Co.
InventorsYang XIAO, Lei WANG, Tae HAN, Baiteng ZHAO
Life of this patent
Estimating the term…
Abstract
The present invention provides PTK7 antibodies, antigen binding portions thereof, other binding agents and PTK7 conjugates thereof, as well as methods and uses of such antibodies and conjugates the treatment of cancer and autoimmune disease.
Claims101
A binding agent comprising:
- a heavy chain variable (VH) region and a light chain variable (VL) region, the VH region comprising complementarity determining regions HCDR1, HCDR2 and HCDR3 disposed in heavy chain variable region framework regions and the VL region comprising LCDR1, LCDR2 and LCDR3 disposed in light chain variable region framework regions, the VH and VL CDRs having amino acids sequences selected from the sets of amino acid sequences set forth in the group consisting of:
- SEQ ID NO:
- 17, SEQ ID NO:
- 18, SEQ ID NO:
- 19, SEQ ID NO:
- 20, KVS and SEQ ID NO:
- 22, respectively;
- SEQ ID NO:
- 3, SEQ ID NO:
- 4, SEQ ID NO:
- 5, SEQ ID NO:
- 6, FAS and SEQ ID NO:
- 7, respectively;
- and
- SEQ ID NO:
- 10, SEQ ID NO:
- 11, SEQ ID NO:
- 12, SEQ ID NO:
- 13, RTS and SEQ ID NO:
- 14, respectively.
17 more elements
-11. (canceled)
-14. (canceled)
-19. (canceled)
-60. (canceled)
(canceled)
(canceled)
(canceled)
-89. (canceled)
(canceled)
-121. (canceled)
(canceled)
-133. (canceled)
-141. (canceled)
Dependencies are inferred from the claim text.